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Abstract
Background: Minimal-access aortic valve replacement (MAAVR) may reduce post-operative blood loss and
transfusion requirements, decrease post-operative pain, shorten length stay and enhance cosmesis. This may be
particularly advantageous in overweight/obese patients, who are at increased risk of post-operative complications.
Obese patients are however often denied MAAVR due to the perceived technical procedural difficulty. This
retrospective analysis sought to determine the effect of BMI on post-operative outcomes in patients undergoing
MAAVR.
Methods: Ninety isolated elective MAAVR procedures performed between May 2006–October 2013 were included.
Intra- and post-operative data were prospectively collected. Ordinary least squares univariate linear regression analysis
was performed to determine the effect of BMI as a continuous variable on post-operative outcomes. One-way ANOVA
and Chi-squared testing was used to assess differences in outcomes between patients with BMI <25 (n = 36) and BMI
≥25 (n = 54) as appropriate.
Results: There was no peri-operative mortality, myocardial infarction or stroke. Univariate regression demonstrated
longer cross-clamp times (p = 0.0218) and a trend towards increased bypass times (p = 0.0615) in patients with higher
BMI. BMI ≥25 was associated with an increased incidence of hospital-acquired pneumonia (p = 0.020) and new-onset
atrial fibrillation (p = 0.036) compared to BMI <25. However, raised BMI did not extend ICU (p = 0.3310) or overall
hospital stay (p = 0.2614). Similar rates of sternal wound complications, inotrope requirements and renal dysfunction
were observed in both normal- and overweight/obese-BMI groups. Furthermore, increasing BMI correlated with
reduced mechanical ventilation time (p = 0.039) and early post-operative blood loss (p = 0.004).
Conclusions: Our results demonstrate that within the range of this study, MAAVR is a safe, reproducible and effective
procedure, affording equivalent clinical outcomes in both overweight/obese and normal-weight patients considered
for an isolated first-time AVR, with low post-operative morbidity and mortality. MAAVR should therefore be considered
as an alternative surgical strategy to reduce obesity-related complications in patients requiring aortic valve
replacement.
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Background
Surgical aortic valve replacement (AVR) via conventional
median sternotomy has been established worldwide as a
safe and feasible intervention for aortic valvular path-
ology [1]. Several minimal access strategies to access the
aortic valve, including right para-sternal thoracotomy,
partial upper hemi-sternotomy, transverse sternotomy, J-
shaped partial upper sternotomy and complete median
sternotomy via a limited skin incision [2–4] have been
employed over the years with the aim of reducing surgical
trauma. The proposed advantages of minimal-access aortic
valve replacement (MAAVR) are reduced post-operative
blood loss and transfusion requirements, reduced post-
operative pain, shorter ventilation times, shorter length of
intensive care unit and hospital stay, and enhanced
cosmesis [2–6]. These benefits have been additionally
validated in higher-risk elderly populations with mul-
tiple medical co-morbidities [7] who may tolerate pro-
longed operative and cardiopulmonary bypass times
less well. However, obese patients are often denied MAAVR
due to the perceived increase in technical difficulty associ-
ated with the procedure in such populations.
Over the past decade we have utilised a J-shaped partial
upper sternotomy in ‘all comers’ as a first-line approach
for MAAVR. In this retrospective analysis, we assess the
effect of body mass index (BMI) on post-operative out-
comes in unselected consecutive patients referred to a
single surgeon for surgical AVR over a 7-year period.
Methods
We performed a retrospective analysis of 90 patients
who underwent elective isolated MAAVR through a J-
shaped partial upper sternotomy between May 2006 and
October 2013 under a single surgeon across three hos-
pital sites (St Mary’s Hospital, Hammersmith Hospital,
and The Wellington Hospital, London, UK). Patients
with a severely-depressed left ventricular ejection frac-
tion (<25 %), sternal deformity, heavy calcification of
the ascending aorta, and concomitant coronary, mitral
valve or tricuspid valve disease were excluded. One case
was a re-operation. Data on pre-, intra-, and post-
operative variables were collected retrospectively from the
hospital cardiac surgical database. Pre-operative patient
characteristics are shown in Table 1.
The surgical technique for aortic valve replacement via
J-shaped partial upper sternotomy has been previously
described [4]. A 6-7 cm midline skin incision is made
over the upper sternum, followed by a limited upper
sternotomy which extends in a “J” shape from the sternal
notch to the right sternal edge at the third intercostal
space. The sternum is spread to a maximum of 6 cm
with a small sternal retractor to minimise stretching and
avoid sternal fracture on the opposite side of the J inci-
sion. After pericardotomy, the aorta and right atrium are
centrally cannulated in a routine manner via an EOPA®
(Medtronic, Inc., USA.) aortic cannula and an Oval
MC2™ (Medtronic, Inc., USA) double-stage venous can-
nula, respectively. Over the last 3 years in an increasing
number of patients, a FlexFlow™ percutaneous double-
stage venous cannula (Sorin Biomedica, Italy) has been
positioned with its tip entering the superior vena cava
under trans-oesophageal echocardiography guidance. An
aortic root cannula is secured to the ascending aorta for
antegrade cardioplegia delivery and venting/de-airing
following aortic cross clamp removal. Cardiopulmonary
bypass and cardioplegic arrest are instituted and main-
tained at moderate hypothermia (32 °C). Continuous
carbon dioxide field-flooding is utilised to reduce the
risk of gas embolisation. After application of an aortic
cross-clamp via the sternal incision, a transverse aor-
totomy is made and aortic valve replacement per-
formed in the standard fashion. The aortotomy is then
repaired with a running suture and adequacy of de-
airing with aortic root venting and/or needle aspiration
is assessed on trans-oesophageal echocardiography.
Temporary pacing wires are sited before removal of
the aortic cross clamp and two 24Fr Blake® (Ethicon, USA)
chest drains are placed via the right fifth intercostal space.
The sternum is closed with steel wires. Post-operatively, all
patients were transferred to the cardiothoracic intensive
Table 1 Pre-operative patient characteristics
Variable MAAVR patients (n = 90)
Age (years) 67.37 ± 15.46
Gender (male/female) 53/37
Height (cm) 167.2 ± 11.72
Weight (kg) 74.85 ± 14.38
Body mass index 26.63 ± 4.07
Hypertension (n) 42 (46.7 %)
Hypercholesterolaemia (n) 30 (33.3 %)
Diabetes (n) 9 (10 %)
Renal insufficiency (n) 1 (1.1 %)
COPD (n) 2 (2.2 %)
Cerebrovascular disease (n) 0 (0 %)
Previous PCI (n) 2 (2.2 %)
Ejection fraction (%) 57.31 ± 14.41
Aortic stenosis (n) 72 (80 %)
Aortic insufficiency (n) 13 (14.4 %)
Mixed stenosis/insufficiency (n) 5 (5.6 %)
Active endocarditis (n) 2 (2.2 %)
Logistic EuroSCORE 6.36 ± 5.5
Continuous variables expressed as mean ± SD
COPD chronic obstructive pulmonary disease, EuroSCORE European Score for
Cardiac Operative Risk Evaluation, MAAVR minimal-access aortic valve replace-
ment, PCI percutaneous coronary intervention
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care unit, sedated and mechanically ventilated in accord-
ance with local protocol. Follow-up with echocardiographic
studies and clinical evaluation was performed at a mean of
2.5 years post-operatively (range 0.021–7.83 years).
Ordinary least squares univariate linear regression ana-
lysis was performed to determine the effect of BMI as a
continuous variable on post-operative outcomes. One-way
analysis of variance (ANOVA) was used to determine the
effect of BMI as a categorical variable (factor 1: normal
weight, BMI <25 vs. factor 2, overweight and obese,
BMI ≥25) on continuous outcome variables. The Chi-
squared statistic was used to determine the effect of the
same BMI categories on binary outcome variables. A p
value less than 0.05 was considered statistically signifi-
cant. Data analysis was performed using StataMP ver-
sion 12.1 (StataCorp, Texas).
Results
Peri-operative outcomes and the correlation of these
outcomes with BMI as both a continuous and categor-
ical variable are shown in Tables 2 and 3 respectively.
28 % of patients undergoing MAAVR in our study were
octogenarians, 51 % were aged over 70 years and 10 %
were younger than 50 years. Mean BMI was 26.63 ± 4.07
(range 18.7–37.2 kg/m2), with 17 patients (19 %) having a
BMI exceeding 30. Aortic valvular pathologies comprised
stenosis in 72 patients, insufficiency in 13 patients and
mixed disease in five patients. In 68 patients (76 %) a
bioprosthesis was implanted, whilst 22 patients (24 %) re-
ceived a mechanical prosthesis. The median size of im-
planted valves was 23 mm (range 19–25 mm).
Intra-operative outcomes and length of stay
There were no conversions to full sternotomy. Univariate
regression demonstrated a significant positive correlation
Table 2 Peri-operative outcomes
Variable MAAVR patients
(n = 90)
Intra-operative conversion to full sternotomy (n) 0
Aortic cross-clamp time (min) 72.7 ± 14.9
CPB time (min) 88.1 ± 17.9
Biological prosthesis (n) 68
Mechanical prosthesis (n) 22
Median valve size (mm) 23 (19–25)
In-hospital mortality (n) 0
Mechanical ventilation time (hours) 6.51 ± 4.14
ICU stay (hours) 48.9 ± 28.9
Overall hospital stay (days) 8.68 ± 6.38
Bleeding at 12 h (ml) 469 ± 391
Re-exploration for bleeding (n) 2
RBC transfusion (n) 22
New-onset atrial fibrillation (n) 27
Respiratory tract infection (n) 4
Renal dysfunction (n) 4
Permanent pacemaker requirement (n) 2
Mechanical circulatory support (n) 1
Sternal instability (n) 0
Sternal wound infection (n) 0
Prosthetic valve endocarditis (n) 0
Myocardial infarction (n) 0
Cerebrovascular accident (n) 0
Continuous variables expressed as mean ± SD
CPB cardiopulmonary bypass, ICU intensive care unit, MAAVR minimal-access
aortic valve replacement, RBC red blood cell
Table 3 Correlation between BMI and peri-operative outcomes.
(a) Ordinary least squares univariate linear regression of BMI as a
continuous variable; (b) Analysis of BMI as a categorical variable
(factor 1 BMI <25 (n = 36) vs. factor 2 BMI ≥25 (n = 54)) using
ANOVA (continuous dependent variables) and chi-squared (binary
dependent variables) statistics
BMI as a continuous variable
Variable r2 Coefficient p
Aortic cross-clamp time 0.072 0.070 0.022
CPB time 0.043 0.045 0.062
Mechanical ventilation time 0.084 −0.295 0.039
ICU stay 0.019 0.941 0.331
Overall hospital stay 0.017 0.080 0.261
Bleeding at 12 h 0.067 −0.003 0.019
Bleeding prior to arrival on ICU 0.091 −0.010 0.031
RBC transfusion 0.034 −1.790 0.190
New-onset atrial fibrillation 0.067 −2.130 0.024
Hospital-acquired pneumonia 0.048 2.870 0.113
BMI as a categorical variable: normal (<25) vs. overweight-obese
(≥25) patients
Variable f Chi2 p
Aortic cross-clamp time 3.43 - 0.068
CPB time 4.93 - 0.029
Mechanical ventilation time 3.60 - 0.064
ICU stay 0.11 - 0.742
Overall hospital stay 0.17 - 0.678
Bleeding at 12 h 6.58 - 0.013
Bleeding prior to arrival on ICU 4.51 - 0.039
RBC transfusion - 0.815 0.367
New-onset atrial fibrillation - 4.410 0.036
Hospital-acquired pneumonia - 5.400 0.020
Renal dysfunction - 0.159 0.690
Continuous variables expressed as mean ± SD
CPB cardiopulmonary bypass, ICU intensive care unit, MAAVR minimal-access
aortic valve replacement, RBC red blood cell; f- f statistic of ANOVA (ratio of
the Mean Square Between (MSB) estimates to Mean Square Error
(MSE) estimates)
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between BMI and cross-clamp time (r2 0.072; coef. 0.070;
p = 0.0218) (Fig. 1). However, BMI was not found to cor-
relate significantly with overall cardiopulmonary bypass
time (r2 0.043; coef. 0.045, p = 0.0615).
A significant negative correlation was also observed be-
tween BMI and ventilation times (r2 0.084; coef. -0.295; p =
0.039) however BMI did not correlate with post-operative
inotrope usage (r2 0.011; coef. 0.364; p = 0.359), intensive
care unit (r2 0.019; coef. 0.941; p = 0.3310) or overall hos-
pital stay (r2 0.017; coef. 0.080; p = 0.2614).
Analysis of BMI as a categorical variable (normal
(BMI < 25) vs. overweight-obese (BMI ≥ 25) demon-
strated a significantly longer overall cardiopulmonary
bypass time (p = 0.029) in overweight-obese patients. No
differences were observed in cross-clamp time (p = 0.068),
ventilation time (p = 0.064), intensive care unit (p = 0.74)
or overall hospital stay (p = 0.68) between normal and
overweight-obese groups.
Post-operative morbidity outcomes
There was no in-hospital myocardial infarction, stroke or
mortality. One patient developed malignant arrhythmia
immediately after coming off cardiopulmonary bypass,
necessitating intra-aortic balloon pump insertion. The
remainder of patients were successfully weaned off car-
diopulmonary bypass without mechanical circulatory
support.
One patient required full sternotomy for cardiac tam-
ponade, and another was re-explored for bleeding but
did not require extension of the original limited sternot-
omy. Two patients underwent permanent pacemaker
implantation post-operatively, one for prolonged pacing
dependence, and another for complete heart block.
A significant positive correlation was observed be-
tween BMI as a continuous variable and the incidence
of post-operative atrial fibrillation (r2 0.067; coef. -2.13;
p = 0.0243). However, BMI was not significantly corre-
lated with the incidence of renal dysfunction (r2 0.004;
coef. 1.12; p = 0.6551), or hospital-acquired pneumonia
(r2 0.048; coef. 2.87; p = 0.113). There were no cases of
sternal dehiscence or infection.
Categorical analysis of normal vs. overweight-obese
patients revealed a significantly higher incidence of AF
(p = 0.036) and post-operative hospital acquired pneu-
monia (p = 0.020) in the overweight-obese group. How-
ever, no differences were observed in renal dysfunction
(p = 0.69) between BMI categories.
Red blood cell transfusion was required in 21 pa-
tients (23 %). BMI demonstrated a significant negative
correlation with bleeding in the immediate post-operative
period prior to arrival on ITU (r2 0.091; coef. -0.0096; p =
0.031) and within the first 12 h post-operatively (r2 0.067;
coef. -0.0027; p = 0.019) (Fig. 2a, b). However, this did not
lead to any significant correlation between BMI and
peri-operative transfusion rates (r2 0.034; coef. -1.70;
p = 0.1899). Similarly, categorical analysis of BMI re-
vealed significantly less post-operative bleeding (prior
to arrival in ITU) and 12-h blood loss (p = 0.039 and
0.013 respectively) in overweight-obese when com-
pared to normal weight patients.
Echocardiographic follow-up
Follow-up echocardiography performed in 35 patients at a
mean 2.5 years (range 0.021–7.83 years) post-operatively
demonstrated trivial para-valvular leak in one patient,
mild para-valvular leak in four patients, and mild-
moderate para-valvular leak in one patient. One patient
with moderate para-valvular leak was re-operated via
the same surgical approach 47 months after the first
MAAVR. No patients required re-operation for pros-
thetic valve endocarditis.
Discussion
Surgical AVR has traditionally been accomplished with
excellent outcomes through a median sternotomy, per-
mitting excellent exposure of the heart and great vessels
[1]. This relatively invasive incision may however produce
significant post-operative pain, impairment of respiratory
function [8, 9], potential for chest wall instability, wound
infection and a visually unattractive scar.
Thus, over the past two decades, several minimal ac-
cess approaches for AVR have been introduced with
variable uptake [2–4]. These have the potential advan-
tages of less post-operative pain, decreased blood loss,
shorter ventilation times, shorter durations of intensive
care unit and hospital stay, faster functional recovery
and favourable cosmesis [2–6] (Fig. 3). Despite these
benefits, several meta-analyses have indicated no signifi-
cant morbidity or mortality difference for patients under-
going either conventional or minimally-invasive AVR [10],
Fig. 1 Univariate linear regression analysis of BMI against cross
clamp time for MAAVR
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and there is little evidence supporting MAAVR in obese
patients.
We sought to determine the effect of BMI on out-
comes in MAAVR performed via J-shaped partial upper
sternotomy. Our results demonstrate that within the
range of this study MAAVR can be safely performed in
patients of higher BMI considered for an isolated first-time
AVR with low post-operative morbidity and mortality.
Our findings demonstrate that MAAVR in patients
with a higher BMI does not lead to prolonged length of
intensive care or overall hospital stay. Furthermore,
although we observed a significant positive correlation
between BMI and cross-clamp time this was not reflected
in total cardiopulmonary bypass times. Indeed, cross-
clamp times were generally similar to those reported by
other groups, who have not demonstrated these to be
significantly longer with minimally invasive incisions
[6, 11, 12]. It can also be expected that once the initial
aspect of the learning curve has been negotiated, op-
erative times in MAAVR may further trend downwards
with accruing surgical experience. In addition, with the
more recent adoption of rapid-deployment ‘sutureless’
aortic prostheses is likely we will see a further decrease aor-
tic cross-clamp and cardiopulmonary bypass times [13].
New-onset atrial fibrillation remains a pertinent issue
after MAAVR, reported in 22–34 % of minimally inva-
sive cohorts analysed by other groups [2, 11, 14, 15]. In
keeping with the findings of previous studies [16, 17],
our results demonstrated a significant positive correl-
ation between new onset post-operative atrial fibrillation
and BMI. Although the exact mechanism for this is
likely to be multifactorial, it has been postulated that left
Fig. 2 Univariate linear regression analysis of BMI against a peri-operative bleeding prior to arrival in ICU; b bleeding in the first 12 h post-operatively
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atrial enlargement as a result of increasing BMI plays a
key role in the setting up and maintenance of atrial fib-
rillation re-entrant circuits [16]. Indeed, our results dem-
onstrate a highly-significant positive correlation between
pre-operative left atrial size and increasing BMI (r2
0.2353; coef. 2.92; p = 0.001), suggesting that obesity-
associated left atrial enlargement may present a quantifi-
able risk factor for the development of new-onset atrial
fibrillation after MAAVR.
No significant correlation was found between BMI and
other post-operative morbidities suggesting that within the
range studied here, increasing BMI should not contraindi-
cate a minimally invasive approach. Furthermore, there
were no deaths in our series over the follow-up period,
supporting evidence from other studies that MAAVR is
associated with similar mortality rates to standard AVR
[1, 3, 8, 9, 11, 15, 18–25].
Using this less-invasive approach comprising only par-
tial sternotomy, a smaller area of exposed sternal bone
marrow and minimised mediastinal dissection should
theoretically produce less bleeding and ultimately im-
proved sternal healing. Indeed, significantly reduced
haemorrhage and blood product utilisation have been re-
ported with MAAVR techniques [6, 15], with acceptable
rates of re-operation for bleeding compared to conven-
tional AVR [14]. In our experience no patients required
intra-operative conversion to median sternotomy. Red
blood cell transfusion was indicated in 26 % of patients
in the present series with only two patients (2.2 %) re-
quiring surgical re-exploration. We did not observe any
increase in post-operative blood loss or transfusion re-
quirement with increasing BMI, and, in fact, a significant
negative correlation was seen between BMI and bleeding
in the first 12 h following surgery. Furthermore, we ob-
served no cases of sternal dehiscence. This highlights
that with meticulous haemostasis, low rates of intra-
operative blood loss may be achieved with MAAVR, in-
dependent of BMI. It is also notable that in the event
of haemorrhage or technical difficulties conversion to
full median sternotomy can still be carried out
expediently.
Limitations
Our study is not without several important limitations.
Firstly, it was a retrospective, non-comparative observa-
tional study comprising a relatively small group of con-
secutive patients referred for surgical AVR. As such, no
direct outcomes comparison of MAAVR to conven-
tional AVR was possible. Secondly, although all opera-
tions were conducted by a single surgeon, this was
across three different institutions, where slight variations
in peri-operative hospital protocols may exist. Thirdly,
only 19 % of our patients were obese (BMI > 30) according
to WHO criteria, and therefore overweight and obese pa-
tients were pooled into a single group for statistical com-
parison. Further work would require a larger sample
population of patients with BMI > 30 to allow this group
to be considered separately. Finally, our study lacks evalu-
ation of patient satisfaction outcome measures, such as
post-operation pain and quality of life, which are pertinent
aspects of a minimal access procedure. We also did not
perform any economic analysis to assess the financial im-
plications of MAAVR in relation to standard AVR, since
this was beyond the scope of our study.
In addition, there are a number of technical consider-
ations that must be taken into account when adopting
this minimal access technique. Although the use of a J-
shaped partial sternotomy removes the requirement for
pre-operative CT scanning to establish the aortic annular
position, as required for approach through a second
intercostal right mini-thoracotomy, it confers some tech-
nical difficulties. Firstly, placement of epicardial pacing
Fig. 3 Post-operative scar following J-shaped partial upper sternotomy for MAAVR
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wires is more demanding, and has to be performed be-
fore removal of the aortic cross clamp in the arrested
heart. Second, internal defibrillation is not possible and
external defibrillator pads must be applied prior to oper-
ation in all patients. Furthermore, removal of air from
the heart after completion of the surgical procedure has
been cited as a particular concern [12, 18], and, as such,
to achieve satisfactory de-airing we employ continuous
carbon dioxide field insufflation and aortic root venting
or needle aspiration under direct trans-oesophageal
echocardiographic monitoring.
Conclusion
Our 7-year data presented here support J-shaped partial
upper sternotomy as a safe, reproducible and effective
approach for MAAVR, offering good short- to mid-term
outcomes in normal, overweight and obese patients. Fur-
ther randomised study of obese patients, specifically with
a BMI > 30 kg/m2 is now required to assess the role of
MAAVR when compared to conventional sternotomy in
this patient group who until now have been considered
unsuitable for such a minimal-access approach.
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